Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
British Journal of Clinical Pharmacology|August 16, 2022
Ocular disorders associated with PCSK9 inhibitors: A pharmacovigilance disproportionality analysisXiaofang Zhao, Jiangfan Wu, Shenyin ZhuExpert Opinion on Drug Safety|December 22, 2024
Concomitant use of sodium-glucose co-transporter 2 inhibitors and metformin and the risk of osteomyelitis reporting: a disproportionality analysis based on FAERS databaseJiangfan Wu, Xin Wang, Xiaofang Zhao, et al.Journal of Diabetes and Its Complications|November 12, 2022
Metabolic effects of the dual SGLT 1/2 inhibitor sotagliflozin on blood pressure and body weight reduction in people with diabetes: An updated meta-analysis of randomized controlled trialsJiangfan Wu, Xiaofang Zhao, Huanhuan Chen, et al.Pharmaceutical Research|February 22, 2024
Research Landscape of Physiologically Based Pharmacokinetic Model Utilization in Different Fields: A Bibliometric Analysis (1999-2023)Xin Wang, Jiangfan Wu, Hongjiang Ye, et al.CPT: Pharmacometrics & Systems Pharmacology|January 8, 2025
Comprehensive Parent-Metabolite PBPK/PD Modeling Insights Into Methotrexate Personalized Dosing Strategies in Patients With Rheumatoid ArthritisXin Wang, Jiangfan Wu, Hongjiang Ye, et al.The Journal of Antimicrobial Chemotherapy|August 29, 2024
Prediction of teicoplanin plasma concentration in critically ill patients: a combination of machine learning and population pharmacokineticsPan Ma, Shenglan Shang, Ruixiang Liu, et al.Pageof 1